ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

New CREGs Announced In Epidemiology, Viruses, Carcinogenesis

April 23, 1976

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

NEW OIG Awards Bring Total to 58

November 13, 1987

Cooperative Groups: Group Affiliates, Statistical Offices At Top Of NCI’s Most Needy Cases List

November 13, 1998

NCI Cooperative Group, Cancer Center Trials Listed

August 29, 2008